X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
oncology (6) 6
chemotherapy (4) 4
humans (4) 4
index medicus (4) 4
adult (3) 3
aged (3) 3
cancer (3) 3
female (3) 3
male (3) 3
medical research (3) 3
middle aged (3) 3
survival (3) 3
advanced melanoma (2) 2
aged, 80 and over (2) 2
antitumor-activity (2) 2
article (2) 2
bevacizumab (2) 2
bioindicators (2) 2
biomarkers (2) 2
carcinoma, non-small-cell lung - drug therapy (2) 2
care and treatment (2) 2
cell lung-cancer (2) 2
checkpoint blockade (2) 2
clinical trials (2) 2
complications and side effects (2) 2
design (2) 2
diagnosis (2) 2
exploration (2) 2
hematology, oncology and palliative medicine (2) 2
lung neoplasms - drug therapy (2) 2
nivolumab (2) 2
open-label (2) 2
radiology (2) 2
solid tumors (2) 2
therapy (2) 2
toxicity (2) 2
treatment outcome (2) 2
1 antibody (1) 1
administration, oral (1) 1
amyloid - chemistry (1) 1
amyloidosis (1) 1
amyloidosis - therapy (1) 1
analysis (1) 1
anti-pd-1 antibody (1) 1
antiangiogenic (1) 1
antiangiogenic therapy (1) 1
antibodies, monoclonal - therapeutic use (1) 1
antigens, cd34 - biosynthesis (1) 1
antimitotic agents (1) 1
antineoplastic agents (1) 1
antineoplastic agents - pharmacology (1) 1
antineoplastic agents - therapeutic use (1) 1
antineoplastic combined chemotherapy protocols - administration & dosage (1) 1
antineoplastic combined chemotherapy protocols - adverse effects (1) 1
antineoplastic combined chemotherapy protocols - pharmacokinetics (1) 1
antineoplastic combined chemotherapy protocols - therapeutic use (1) 1
autologous hematopoietic transplantation (1) 1
b7-h1 antigen - biosynthesis (1) 1
b7-h1 antigen - immunology (1) 1
biopsy (1) 1
bone marrow (1) 1
bone marrow transplantation - methods (1) 1
brain (1) 1
brain metastases (1) 1
cancer research (1) 1
carcinoma (1) 1
carcinoma, non-small-cell lung - immunology (1) 1
carcinoma, non-small-cell lung - metabolism (1) 1
cisplatin plus gemcitabine (1) 1
clinical activity (1) 1
clinical trials as topic (1) 1
cohort studies (1) 1
colchicine (1) 1
disease control (1) 1
disease-free survival (1) 1
docetaxel (1) 1
dosage and administration (1) 1
dose-response relationship, drug (1) 1
dosing (1) 1
drug administration schedule (1) 1
drug development (1) 1
evaluation (1) 1
glutamates - administration & dosage (1) 1
glutamates - adverse effects (1) 1
glutamates - pharmacokinetics (1) 1
glutamates - therapeutic use (1) 1
guanine - administration & dosage (1) 1
guanine - adverse effects (1) 1
guanine - analogs & derivatives (1) 1
guanine - pharmacokinetics (1) 1
guanine - therapeutic use (1) 1
health aspects (1) 1
hematology (1) 1
hematopoietic stem cell mobilization (1) 1
high-dose melphalan (1) 1
iii trial (1) 1
immune checkpoint (1) 1
immunology (1) 1
immunotherapy trials (1) 1
indoles - administration & dosage (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Annals of Oncology, ISSN 0923-7534, 04/2018, Volume 29, Issue 4, pp. 959 - 965
Abstract Background Long-term data with immune checkpoint inhibitors in non-small-cell lung cancer (NSCLC) are limited. Two phase III trials demonstrated... 
NSCLC | Liver metastases | Nivolumab | SURVIVAL | DIAGNOSIS | TRIALS | nivolumab | ONCOLOGY | liver metastases
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 02/2014, Volume 88, Issue 2, pp. 503 - 504
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2014, Volume 88, Issue 2, pp. 503 - 504
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 11/2014, Volume 90, Issue 5, pp. S33 - S34
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2014, Volume 90, Issue 5, pp. S33 - S34
Journal Article
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 3/2012, Volume 69, Issue 3, pp. 709 - 722
The primary objective of this phase I dose-escalation study was to identify the maximum tolerated dose (MTD) of sunitinib plus pemetrexed in patients with... 
Sunitinib | Phase I | Medicine & Public Health | Tyrosine kinase inhibitor | Lung cancer | Cancer Research | Oncology | Solid tumors | Pharmacology/Toxicology | Antiangiogenic | Pemetrexed | NEUROENDOCRINE TUMORS | BEVACIZUMAB | ANTITUMOR-ACTIVITY | SU11248 | CHEMOTHERAPY | ANTIANGIOGENIC THERAPY | CISPLATIN PLUS GEMCITABINE | ONCOLOGY | PHARMACOLOGY & PHARMACY | CARCINOMA | III TRIAL | Glutamates - therapeutic use | Lung Neoplasms - drug therapy | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Pyrroles - pharmacokinetics | Glutamates - adverse effects | Guanine - analogs & derivatives | Humans | Lung Neoplasms - metabolism | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - pharmacokinetics | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Indoles - administration & dosage | Dose-Response Relationship, Drug | Pyrroles - administration & dosage | Aged, 80 and over | Pyrroles - adverse effects | Adult | Female | Guanine - adverse effects | Pyrroles - therapeutic use | Guanine - therapeutic use | Drug Administration Schedule | Administration, Oral | Guanine - pharmacokinetics | Carcinoma, Non-Small-Cell Lung - metabolism | Glutamates - pharmacokinetics | Treatment Outcome | Maximum Tolerated Dose | Indoles - adverse effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Glutamates - administration & dosage | Indoles - pharmacokinetics | Indoles - therapeutic use | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Cohort Studies | Guanine - administration & dosage | Tyrosine | Medical research | Care and treatment | Questions and answers | Lung cancer, Non-small cell | Antineoplastic agents | Antimitotic agents | Complications and side effects | Analysis | Medicine, Experimental | Tumors | Cancer | Index Medicus | Original
Journal Article
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 09/2017, Volume 23, Issue 17, pp. 4959 - 4969
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.